Start: where your validation pressure is felt

• Tell me briefly how many GxP-regulated systems are currently in your validation backlog Options: 1-5, 6-20, 21-50, More than 50, Unsure
• How many of those systems are in active implementation right now versus awaiting a validation slot Options: Mostly active implementations, Mostly awaiting validation, Even split, Unsure
• Who on your team is the day-to-day owner for scheduling and tracking validation activities Options: Quality director, Validation manager, IT lead, Shared responsibility, Other (please name)
• Describe the last time a system release was delayed for validation reasons and what the business impact was
• What single outcome would make you stop a validation engagement before it begins Options: Insufficient named owners, No access to test environments, Vendor refuses documentation access, Cost exceeds budget, Other (explain)

Where inspection and regulatory risk bites

• If an inspector asked for traceable IQ/OQ/PQ evidence tomorrow, which of your systems would leave you most exposed Options: LIMS-type systems, MES-type systems, eQMS / QMS systems, Clinical data platforms, Multiple across categories, Unsure
• Which recent inspection observations or internal audit findings still shape your validation priorities today Options: Documentation gaps, Missing test evidence, Change control issues, Access control / 21 CFR Part 11 items, None currently, Other (explain)
• In your most recent inspection or audit, which documentation gaps were explicitly called out and who had to respond
• How often do vendor upgrades or emergency patches force revalidation work across your estate Options: Monthly, Quarterly, Twice a year, Annually, Ad hoc
• What regulatory risk or unresolved finding would make you halt new system rollouts immediately Options: Open critical audit finding, Widespread missing IQ/OQ/PQ, No validated backup procedures, Access control failures, Other (explain)

Inventory: the systems, configs, and evidence we'll need

• Walk me through how your current inventory and configuration baseline would stand up to an inspection request for vendor docs and traceability
• List the system categories and the typical vendor documentation you already have for each Options: LIMS - vendor IQ/OQ, installation guides, MES - integration diagrams, config exports, eQMS - security config, audit trail settings, Clinical data - validation specs, reconciliation evidence, Other (describe)
• Do you have consolidated storage for vendor documents, test scripts, and validation artifacts that an external consultant can be granted read access to Options: Yes, centralized repository with read access, Partial, some systems only, No, scattered across teams, Access requires manual approval each time
• Which role or team owns API keys, integration credentials, and test endpoints for each critical system Options: Platform engineering, Application owner, Vendor-managed, Shared between IT and vendor, Not defined
• How many distinct system versions or instances typically require separate IQ/OQ/PQ execution in a given program Options: Single instance per system, 2-3 instances, 4-10 instances, More than 10, Varies widely
• If key vendor documentation cannot be accessed within two weeks for a critical system, would that stop the pilot or force a scoped delay Options: Stop the pilot, Delay and scope alternatives, Proceed with partial evidence, Escalate to vendor for faster delivery

Scope and success: defining the deliverables that remove doubt

• Which deliverables would you insist on receiving before approving a system for production use Options: Validation master plan, Executed IQ/OQ/PQ protocols, Signed deviation logs, Executive summary and trace matrix, All of the above, Other (explain)
• Describe the acceptance criteria your quality team uses to sign off on IQ/OQ/PQ packages
• Name the roles that must sign final acceptance and the single piece of evidence that usually tips the decision for them
• Your target turnaround for seller responses to deviation investigations, in business days Options: 2 business days, 5 business days, 10 business days, Depends on severity
• At what point, in days or as a percent delay, would you pause further validation work on a system Options: 7 days / 10% delay, 14 days / 25% delay, 30 days / 50% delay, We do not pause, we escalate

The other options you're evaluating

• List the alternatives you are actively evaluating right now to clear the validation backlog, including internal options Options: Internal validation team ramp, Existing vendor partner, New external validation firm, Temporary contractors, No decision yet
• Under what conditions would you decide to continue with your current internal approach instead of engaging an outside partner Options: Sufficient internal headcount, Favorable inspection posture, Low system change rate, Budget constraints, Other (explain)
• Are there internal champions who prefer handling validation in-house or a current incumbent vendor the team would default to Options: Strong in-house champion, Incumbent vendor preferred, Neutral, open to options, Multiple competing opinions
• Assuming the pilot validates your key metrics, what would prevent fast contract approval within two weeks Options: Procurement delays, Budget approvals, Legal review, Leadership bandwidth, Nothing prevents it
• Please indicate which of these options are under active consideration right now Options: Continue internal validation, Pilot with an external firm, Full program with a vendor, Hybrid (internal + external), No plan yet

Are you ready to run: prerequisites and hard constraints

• Identify any critical dependencies that are not yet in place that could block a pilot starting next month Options: Named system owners, Read/test access to environments, Vendor technical docs, Procurement approval, None of the above
• Where does the source documentation and test evidence for each target system currently live, and can the seller be granted read access Options: Central document repository, Shared drives per team, Vendor portal, Scattered emails and attachments, Access needs approval
• Name the IT owner who will approve access and describe the typical provisioning process
• Assess how clean and exportable the data the validation relies on is, and when that data was last reconciled Options: Fully exportable and reconciled within 1 month, Partially exportable, reconciled within 3 months, Export requires custom scripts, reconciliation older than 3 months, Unknown
• Can your team provide alternative test harnesses within four weeks if key integrations lack APIs or vendor support Options: Yes, we have in-house test harness capability, Maybe with additional effort, No, we rely on vendor support, Not applicable
• Select any infrastructure prerequisites that apply to your environment Options: Dedicated test environment available, Sandbox with production-like data, Named VPN or jump host for vendor, Vendor cannot access test environments, Environments must be provisioned

Commitment and next steps that accelerate value

• Assuming the pilot proves the approach and evidence, what internal approvals will be required to convert a pilot into a program Options: Quality approval, IT approval, Procurement sign-off, Executive sponsorship, All of the above
• In your procurement practice, which payment milestones are acceptable for a multi-system validation program Options: Pilot completion, Phased system delivery, Monthly retainer, Milestone + holdback, Other (explain)
• Provide the roles that should sit on a pilot steering committee and identify the single point of contact for day-to-day coordination
• Can leadership commit to signing a program-level SOW within one week if the pilot meets predefined success metrics Options: Yes, Maybe with conditions, No
• Identify the procurement concern that would prevent approval of a multi-system engagement after a successful pilot
• Select your earliest realistic pilot start after a mutually agreed SOW Options: Immediately, Within 2 weeks, Within 4 weeks, 8 weeks or more

• Engagement Assumptions and Scope Confirmation
• System Inventory Capture (site-specific)
• Vendor Documentation Indexing and Gap Report
• Configuration Baseline and Test Evidence Requirements
• Traceability Matrix Draft and Pilot Test Script Prioritization

• Produce a configuration baseline document containing exported settings and agreed acceptance criteria.
• Issue the prioritized document request list to vendors or internal teams with target due dates.
• Log vendor response deadlines and escalation points for any high-risk documentation gaps.
• Review available configuration exports and artifacts
• An agreed configuration baseline per targeted system with documented acceptance criteria for key settings.
• A definitive list of test evidence types and capture methods required for IQ, OQ, and PQ activities.
• A confirmed approach for test data handling that satisfies regulatory and privacy constraints.
• Re-state scope and success criteria
• Create a test evidence checklist that lists required artifacts and the method to capture each.
• Prepare a test data plan describing masking, synthetic data creation, or environment separation requirements.
• Map regulatory and user requirements to systems
• A draft requirements-to-test traceability matrix that links each requirement to at least one test and the expected evidence.
• A prioritized list of pilot test scripts with clear steps and acceptance criteria ready for development.
• A confirmed readiness check and timeline for pilot test script development and execution.
• Deliver the draft traceability matrix populated with the session's mappings.
• Draft the detailed pilot test scripts for the prioritized list and circulate for review.
• Confirm and document the pilot schedule, environment reservations, and data preparation tasks.
• A signed list of in-scope systems and sites with clear inspection-readiness success criteria.
• Documented engagement assumptions and constraints that will guide subsequent working sessions.
• A replication plan specifying which sessions will be run per site or per system and the schedule for those sessions.
• Publish the agreed in-scope systems and sites with success criteria as the working-scope document.
• Generate and distribute the initial data and document request list with due dates.
• Schedule the site-specific System Inventory Capture sessions according to the replication plan.
• Quick scope recap for this site
• A completed site-level system inventory with required metadata fields populated or flagged for follow-up.
• A captured list of system interfaces and data flows that will inform test scope and environment needs.
• A prioritized list of systems per site for pilot or near-term validation work.
• Populate the master system inventory spreadsheet for the site with all captured metadata.
• List missing metadata fields for each system and schedule targeted follow-ups to complete them.
• Collect or request any immediately available configuration exports or screenshots identified during the session.
• Confirm required vendor document types
• A vendor document index that shows which documents exist for each system and which evidence requirements are satisfied.
• A prioritized gap report listing missing or inadequate documents with risk ratings and target acquisition timelines.
• An agreed plan for obtaining missing vendor documentation or acceptable compensating evidence.
• Deliver the vendor documentation index and gap report based on materials reviewed in the session.
• Review and record assumptions and constraints
• Confirm critical configuration elements and their acceptance criteria
• Draft mappings from requirements to test scripts and evidence fields
• Map available documents to each in-scope system
• Walk each system and capture core metadata
• Specify required test evidence types and capture methods
• Identify missing, outdated, or insufficient documents and assess risk
• Prioritize and define pilot test scripts with acceptance criteria
• Document interfaces and integrations
• Define per-site and per-system replication plan
• Agree immediate data requests and owners
• Identify configuration export availability and evidence sources
• Confirm readiness for test script development and pilot scheduling
• Agree an acquisition plan and timelines
• Agree data handling and anonymization approach for test data
• Validate inventory completeness and capture unknowns

• Author IQ/OQ/PQ Protocols
• Develop Test Scripts and Test Cases
• Execute Installation Qualification (IQ)
• Execute Operational Qualification (OQ)
• Execute Performance Qualification (PQ)
• Create Requirements-to-Test Traceability Matrix
• Manage Deviations and CAPA Documentation
• Verify Vendor Technical and Design Documentation
• Validate Electronic Records and Audit Trails
• Prepare 21 CFR Part 11 Compliance Evidence
• Prepare EU Annex 11 Compliance Evidence
• Compile Inspection-Ready Validation Package

Author IQ/OQ/PQ Protocols

• Do you have an existing validation master plan (VMP) that defines protocol templates to follow? Options: Yes, No, Partial / VMP draft available
• Which user requirements specification (URS) and functional requirement documents must the IQ/OQ/PQ map to?
• How many distinct system configurations will require separate IQ protocols (for example different builds, hardware variants, or cloud tenants)? Options: 1, 2-3, 4-10, More than 10
• Who on your team will approve protocol deviations and provide final protocol sign-off?
• Describe any recent inspection findings or regulatory expectations (for example 21 CFR Part 11 citations) that should influence protocol content.
• Do you require protocol templates to include step-level acceptance criteria with pass/fail thresholds for critical tests? Options: Yes - include numeric thresholds, Yes - qualitative pass/fail, No - we will supply acceptance criteria separately

Develop Test Scripts and Test Cases

• Which user scenarios and GxP workflows should be covered by the test scripts (for example sample receipt, result approval, batch release)?
• How many traceable test cases are required per system to meet your internal QA coverage targets? Options: Less than 50, 50-200, 201-500, More than 500
• Who will own execution of test scripts in the IQ/OQ/PQ phases and who will be responsible for recording evidence (for example screenshots, signed logs)?
• Provide the preferred format for test evidence (screen captures, system logs, signed CSV records) and any filename or metadata conventions. Options: PDF bundles, Time-stamped screenshots + CSV logs, System export with checksum, Other
• Is automated test execution required for any workflows, and if so which interfaces or APIs need automation coverage? Options: No automation required, Yes - API level scripts, Yes - UI automation, Partial / specific modules only
• Describe any vendor-supplied test tools or reusable scripts you expect to leverage during testing.

Execute Installation Qualification (IQ)

• List the hardware and network diagrams (for example rack drawings, single-line diagrams) that must be validated during IQ.
• Specify the environments (development, test, staging, production) that require IQ execution and any environment-specific constraints. Options: Development, Test/QA, Staging, Production
• Identify the individual or role that will provide signed installation evidence such as build logs and configuration baselines.
• Are there approved standard operating procedures (SOPs) for installation steps that must be referenced in IQ protocols? Options: Yes - SOPs available, No - SOPs need drafting, Partial - some SOPs available
• Provide the acceptable variance thresholds for configuration parameters (for example maximum allowed deviation in system clock, timezone configuration, or network latency) during IQ.
• When will vendor-supplied hardware certification or factory acceptance test (FAT) reports be available for inclusion in IQ evidence? Options: Available now, 2 weeks before IQ, 1 month before IQ, Vendor TBD

Execute Operational Qualification (OQ)

• List critical functional tests that must be included to demonstrate controls operate under expected conditions (for example audit trail writes/reads, role-based access enforcement).
• Identify any third-party integrations (for example LIMS, MES, EHR) whose interfaces need OQ coverage and data exchange validation.
• Are performance thresholds defined for throughput, transaction latency, or concurrent users that must be met during OQ? Options: Yes - thresholds provided, No - thresholds to be defined, Partial - only for select modules
• Name the role that will review and approve OQ deviations and interim test reports.
• Specify the negative or boundary tests required during OQ (for example invalid user input, network interruption, concurrent user limits).
• Explain the change control workflow for configuration changes discovered during OQ and the required artifacts for change records.

Execute Performance Qualification (PQ)

• Name the production-like datasets and load profiles you will provide to validate performance under operational conditions.
• Does your quality risk assessment require worst-case batch sizes or sample volumes to be executed during PQ (for example maximum batch size for release testing)? Options: Yes - worst-case required, No - sample-based, Conditional - only for critical modules
• State which role will sign final PQ summary reports and product release recommendations.
• Explain required environmental monitoring or sample retention procedures tied to PQ acceptance criteria.
• Detail the throughput metrics (transactions per hour, concurrent users) that determine PQ pass/fail.
• When do you expect the production environment and production data to be available for PQ runs? Options: Available now, 1 week prior, 2 weeks prior, Not scheduled

Create Requirements-to-Test Traceability Matrix

• What percentage of user requirements must have a mapped test case in the requirements-to-test traceability matrix (for example 100%, 95%)? Options: 100%, 95%, 90%, Other (specify)
• Define the naming convention the traceability matrix should use to align with your validation change control records.
• State the frequency the matrix should be updated during testing cycles and who is responsible for updates.
• Enumerate the minimum evidence artifacts (for example test execution logs, screenshots, signed test records) that must be linked from each test case.
• Is automated linking between your requirements repository and test management tool required to maintain traceability? Options: Yes - automated linking required, No - manual updates acceptable, Partial - hybrid approach
• Indicate the repository or tool where the traceability matrix will be stored and version-controlled (for example document management system, test management tool).

Manage Deviations and CAPA Documentation

• Clarify the required deviation report elements (for example root cause, impact assessment, containment actions) that must be captured in the deviation record.
• Outline the CAPA workflow and approval gates that must be followed when a deviation triggers corrective action.
• Point out the role authorized to close CAPAs and the repository where closure evidence is stored.
• Confirm whether deviation trending and KPIs (for example CAPA aging, recurrence rate) are required as part of periodic quality reviews. Options: Yes - trending required, No - not required, Optional - based on severity
• Detail the required linkage between deviation records and change control documents for any corrective action that modifies system configuration.
• Indicate the notification timeline for auditors after a major deviation per your SOPs. Options: Immediately, Within 24 hours, Within 72 hours, Per SOP-defined timeline

Verify Vendor Technical and Design Documentation

• Enumerate the vendor documents you require for verification (for example design specifications, installation guides, release notes, change logs).
• Clarify whether vendor software version history and validated build artifacts are required for each release included in scope. Options: Yes - required for each release, Only for major releases, Not required
• Outline expectations for vendor responses when technical gaps are found during documentation review, including timelines for remediation.
• Determine whether vendor-supplied source code or binary checksum verification is required for any regulated module. Options: Yes - checksum required, No - checksum not required, Only for critical components
• Assign the role responsible for coordinating requests for missing vendor documentation and tracking vendor deliverables.
• Indicate the deadline for vendor documentation availability relative to protocol execution start (for example 2 weeks prior). Options: Available now, 1 week prior, 2 weeks prior, 4 weeks prior

Validate Electronic Records and Audit Trails

• Does your system need to capture audit trail events such as create, modify, delete of GxP records and specify the retention period for those logs? Options: Yes - retention period provided, Yes - retention period to be defined, No - limited audit trails
• Present the method you will use to demonstrate audit trail integrity for electronic records during an inspection (for example immutable logs, checksums, signed export).
• Does your system allow export of audit trail reports in both human- and machine-readable formats for inspection? Options: Yes - both formats available, Only human-readable, Only machine-readable, Not available
• Declare the retention policy that aligns with your regulatory obligations for electronic records (for example 2 years, 7 years, product life). Options: 2 years, 5 years, 7 years, Product lifecycle, Other
• Assign the role responsible for producing audit trail extracts and signing the evidence for inspection.
• Flag any regulated fields where edit history must be preserved beyond standard audit trails (for example electronic batch records).

Prepare 21 CFR Part 11 Compliance Evidence

• Catalog the 21 CFR Part 11 elements your auditors expect documentary evidence for (for example electronic signatures, audit trails, system access controls).
• What evidence will validate system compliance for electronic signatures and user access under 21 CFR Part 11 (for example signature manifestations, signed audit logs)?
• Declare the date of the last review of user access and signature policies and whether they align to your SOPs for record retention.
• Confirm whether evidence of periodic revalidation is required for legacy systems claimed validated under Part 11 or whether initial validation evidence is sufficient. Options: Periodic revalidation required, Initial validation only, Case-by-case basis
• Designate the authorized person who will attest to Part 11 evidence during an inspection and state where signed attestations will be stored.

Prepare EU Annex 11 Compliance Evidence

• Catalog the Annex 11 areas that require documentary evidence in your scope (for example data integrity controls, electronic records lifecycle, supplier oversight).

• Master Services Agreement (MSA)
• Statement of Work (SOW)
• Payment Milestone Schedule
• Non-Disclosure Agreement (NDA)
• Data Processing Agreement (DPA)
• Access & Vendor Cooperation Addendum
• Roles & Responsibilities Annex
• Change Order Agreement
• Regulatory Compliance Addendum (GxP / 21 CFR Part 11 / EU Annex 11)
• Commencement Authorization

• success_criteria
• stakeholders
• current_state
• decision_readiness
• gaps
• desired_state
• stakeholders
• success_criteria
• decision_readiness
• current_state
• desired_state
• gaps
• stakeholders
• decision_readiness
• current_state
• gaps
• decision_readiness
• current_state
• decision_readiness
• decision_readiness
• decision_readiness

• Go-live Health Check (weeks 1-4)
• First Outcome Measurement (weeks 4-10)
• 90-Day Realization and Remediation Review
• Quarterly Sustainment Review

• Schedule any necessary interim technical or working sessions to address high-risk items before the next quarterly review.
• Restate acceptance criteria and current pass rate
• Document which acceptance criteria from Engagement Scope are met and which remain, without re-issuing formal acceptance.
• Agree binding remediation timelines for all remaining deviations and missing evidence.
• Confirm archival location and format for inspection-ready validation packages and one sample package verification.
• Publish the 90-day realization report listing met criteria, outstanding items, and timelines.
• Complete archival of finalized validation packages and confirm sample verification results.
• Open escalation paths for any remediation items not on track at the next weekly checkpoint.
• Review open deviations and incident burn-down
• Reduce open deviations count and improve average days to close deviations quarter over quarter.
• Maintain or increase the number of systems with inspection-ready documentation as recorded in Engagement Scope.
• Ensure the enhancement backlog is triaged and that any item requiring re-validation is scheduled with a timeline.
• Update the deviation register with close dates and reasons for any reopenings.
• Publish the quarterly inspection-readiness summary and the updated enhancement backlog with prioritization.
• Re-confirm success criteria and named owners
• Confirm each acceptance criterion in Engagement Scope has a named owner and an initial status update.
• Identify and document all high-priority blockers preventing validation evidence collection or use of the system.
• Agree a remediation plan and the communication channel for daily or weekly updates until the first measurement meeting.
• Publish the go-live health summary and owner-assigned issue tracker within 24 hours.
• Validate and document environment access and vendor documentation locations required for ongoing validation work.
• Schedule the First Outcome Measurement meeting and confirm data sources to be used for metrics.
• Present first outcome data against Engagement Scope targets
• Validate the current count of inspection-ready validation packages closed versus the target recorded in Engagement Scope.
• Confirm the percentage of test scripts executed with passing evidence and identify top 3 reasons for any failures.
• Agree a remediation plan with deadlines to resolve open deviations and bring metrics to target by the next review.
• Publish the measurement dashboard extract and the root-cause summary within 48 hours.
• Create and assign remediation tasks for each open deviation with target close dates.
• Confirm data ownership and instrument data pulls for the next measurement checkpoint.
• Detailed review of unresolved remediation items
• Root-cause analysis for gaps
• Deployment and environment validation
• Inspection readiness status per system
• Enhancement and change request backlog
• Early adoption signals and user onboarding
• Evidence packaging and archival confirmation
• Deviations and remediation status
• Support channel and SLA health
• Open issues and blockers triage
• Agree corrective actions, owners, and dates
• Agree final remediation timeline and monitoring cadence
• Short-term action plan and next check
• Agree immediate remediation actions and communication channel